Ironwood Wins FDA Approval for Pediatric LINZESS
BOSTON — May 27, 2026 Ironwood Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has approved an...
AI drug discovery AI healthcare artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma Biopharmaceuticals Biotechnology Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology oncology innovation Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine targeted therapy
BOSTON — May 27, 2026 Ironwood Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has approved an...
GLASGOW, Scotland, April 29, 2026 EnteroBiotix Limited has announced the successful completion of a £19 million ($25 million) financing...
